Kim Euikyung, Hwang Du Hyeon, Mohan Prakash Ramachandran Loganathan, Asirvatham Ravi Deva, Lee Hyunkyoung, Heo Yunwi, Munawir Al, Seyedian Ramin, Kang Changkeun
College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
Institute of Animal Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
Toxins (Basel). 2025 Jul 28;17(8):371. doi: 10.3390/toxins17080371.
Animal venoms are complex biochemical secretions rich in highly potent and selective bioactive molecules, including peptides, enzymes, and small organic compounds. Once associated primarily with toxicity, these venoms are now recognized as a promising source of therapeutic agents for a wide range of medical conditions. This review provides a comprehensive analysis of the pharmacological potential of venom-derived compounds, highlighting their mechanisms of action, such as ion channel modulation, receptor targeting, and enzyme inhibition. Successful venom-derived drugs like captopril and ziconotide exemplify the translational potential of this biological arsenal. We discuss therapeutic applications in cardiovascular diseases, chronic pain, cancer, thrombosis, and infectious diseases, as well as emerging peptide candidates in clinical development. Technological advancements in omics, structural biology, and synthetic peptide engineering have significantly enhanced the discovery and optimization of venom-based therapeutics. Despite challenges related to stability, immunogenicity, and ecological sustainability, the integration of AI-driven drug discovery and personalized medicine is expected to accelerate progress in this field. By synthesizing current findings and future directions, this review underscores the transformative potential of animal venoms in modern pharmacotherapy and drug development. We also discuss current therapeutic limitations and how venom-derived compounds may address unmet needs in specific disorders.
动物毒液是复杂的生化分泌物,富含高效且具选择性的生物活性分子,包括肽、酶和小有机化合物。这些毒液曾经主要与毒性相关,如今被视为多种医疗状况下有前景的治疗药物来源。本综述全面分析了毒液衍生化合物的药理潜力,突出了它们的作用机制,如离子通道调节、受体靶向和酶抑制。像卡托普利和齐考诺肽这样成功的毒液衍生药物例证了这一生物宝库的转化潜力。我们讨论了在心血管疾病、慢性疼痛、癌症、血栓形成和传染病方面的治疗应用,以及临床开发中的新兴肽候选物。组学、结构生物学和合成肽工程方面的技术进步显著增强了基于毒液的治疗药物的发现和优化。尽管存在与稳定性、免疫原性和生态可持续性相关的挑战,但人工智能驱动的药物发现与个性化医疗的整合有望加速该领域的进展。通过综合当前研究结果和未来方向,本综述强调了动物毒液在现代药物治疗和药物开发中的变革潜力。我们还讨论了当前的治疗局限性以及毒液衍生化合物如何满足特定疾病中未满足的需求。